“Our algorithms can automatically scan all the patient parameters and detect subtle changes over time to find correlative patterns for outcomes we want to predict,” Nir Kalkstein, Medial’s co-founder and chief technology officer, says.
Read the BusinessWeek article here.
ColonFlag is not available for sale in the U.S.